HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xinyu Du Selected Research

MicroRNAs (MicroRNA)

3/2021MiRNA: a potential target for gene diagnosis and treatment of atherosclerotic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xinyu Du Research Topics

Disease

3Inflammation (Inflammations)
12/2022 - 10/2016
2Breast Neoplasms (Breast Cancer)
09/2023 - 09/2023
2Pathologic Constriction (Stenosis)
08/2023 - 08/2022
2Crohn Disease (Crohn's Disease)
08/2023 - 08/2022
2Hepatitis C
03/2023 - 08/2022
2Stomach Neoplasms (Stomach Cancer)
01/2023 - 05/2021
2Diarrhea
12/2022 - 09/2022
2Infections
12/2022 - 09/2022
1Cerebral Hemorrhage
03/2024
1Colitis
12/2023
1Colonic Neoplasms (Colon Cancer)
09/2023
1Polyps
09/2023
1Myocardial Infarction
05/2023
1Autoimmune Diseases (Autoimmune Disease)
03/2023
1Rheumatoid Arthritis
03/2023
1Osteoporosis
01/2023
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2023
1Poisoning
10/2022
1Rhabdomyolysis
10/2022
1Disease Progression
08/2022
1Death (Near-Death Experience)
07/2022
1Hypertension (High Blood Pressure)
01/2022
1Atherosclerosis
03/2021
1Ischemic Stroke
03/2021
1Reperfusion Injury
03/2021
1Stroke (Strokes)
03/2021
1Cognitive Dysfunction
01/2021
1Substance-Related Disorders (Drug Abuse)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Shock
03/2020

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2021
2Antihypertensive Agents (Antihypertensives)IBA
03/2024 - 01/2022
2OligosaccharidesIBA
08/2023 - 08/2022
2carboxymethyl-chitosanIBA
08/2023 - 08/2022
2omega-Chloroacetophenone (Mace)IBA
05/2023 - 01/2023
2Antiviral Agents (Antivirals)IBA
03/2023 - 08/2022
2ZincIBA
12/2022 - 09/2022
1Remifentanil (Ultiva)FDA Link
03/2024
1DexmedetomidineFDA Link
03/2024
1Carotenoids (Carotene)IBA
12/2023
1ApolipoproteinsIBA
09/2023
1Serine-tRNA LigaseIBA
09/2023
1Phenobarbital (Luminal)FDA Link
09/2023
1ORALIT (ORS)IBA
09/2023
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2023
1SeleniumIBA
01/2023
1CadmiumIBA
01/2023
1Heavy MetalsIBA
01/2023
1AcidsIBA
10/2022
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2022
1DiquatIBA
10/2022
1GlucocorticoidsIBA
10/2022
1MyoglobinIBA
10/2022
1Virulence Factors (Pathogenicity Factors)IBA
09/2022
1Enterotoxins (Enterotoxin)IBA
09/2022
1Ethanol (Ethyl Alcohol)IBA
08/2022
1SolutionsIBA
08/2022
1Trinitrobenzenesulfonic AcidIBA
08/2022
1Mesalamine (Mesalazine)FDA LinkGeneric
08/2022
1MicroplasticsIBA
07/2022
1Circular RNAIBA
03/2021
1MicroRNAs (MicroRNA)IBA
03/2021
1Ghrelin ReceptorsIBA
01/2021
1N- (1- (4- (4- methoxybenzyl)- 5- phenethyl- 4H- 1,2,4- triazol- 3- yl)- 2- (1H- indol- 3- yl)ethyl)- 2- aminoacetamideIBA
01/2021
1Thiamine PyrophosphateIBA
01/2021
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2021
1Morphine (MS Contin)FDA LinkGeneric
01/2021
1CytokinesIBA
10/2016
1Glucose (Dextrose)FDA LinkGeneric
10/2016
1Interleukin-17 (Interleukin 17)IBA
10/2016

Therapy/Procedure

1Injections
12/2023
1Continuous Renal Replacement Therapy
10/2022
1Aftercare (After-Treatment)
10/2022
1Hemoperfusion
10/2022
1Enema (Enemas)
08/2022
1Therapeutics
08/2022
1Drug Therapy (Chemotherapy)
03/2021
1Surgical Instruments (Clip)
03/2020